Capstone Investment Advisors, LLC Eli Lilly & CO Transaction History

Capstone Investment Advisors, LLC

$24.9 Billion
Q1 2024

A detailed history of Capstone Investment Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Capstone Investment Advisors, LLC holds 106,000 shares of LLY stock, worth $96.9 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares

106,000

Previous 173,400 38.87%

Holding current value

$96.9 Million

Previous $101 Million 18.42%

% of portfolio

0.33%

Previous 0.33%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	BUY	$592.2 - $792.28 $314,458 - $420,700	531 New	531 $413,000
Q3 2023 Nov 13, 2023	BUY	$434.7 - $599.3 $2.7 Million - $3.72 Million	6,200 New	6,200 $3.33 Million
Q1 2023 May 09, 2023	BUY	$310.63 - $364.82 $283,605 - $333,080	913 Added 98.6%	1,839 $631,000
Q4 2022 Feb 10, 2023	BUY	$321.55 - $374.67 $297,755 - $346,944	926 New	926 $338,000
Q2 2022 Aug 15, 2022	SELL	$278.73 - $327.27 $5.21 Million - $6.12 Million	-18,707 Reduced 81.98%	4,112 $1.33 Million

Q1 2022 May 13, 2022	BUY	$234.69 - $291.66 $4.77 Million - $5.92 Million	20,307 Added 808.4%	22,819 $6.54 Million
Q4 2021 Feb 11, 2022	SELL	$224.85 - $279.04 $1.45 Million - $1.8 Million	-6,457 Reduced 71.99%	2,512 $694,000
Q3 2021 Nov 15, 2021	SELL	$221.6 - $272.71 $8.98 Million - $11 Million	-40,516 Reduced 81.88%	8,969 $2.07 Million
Q2 2021 Aug 16, 2021	BUY	$180.55 - $233.54 $6.66 Million - $8.62 Million	36,894 Added 293.02%	49,485 $11.4 Million
Q1 2021 May 17, 2021	BUY	$164.32 - $212.72 $1.76 Million - $2.27 Million	10,687 Added 561.29%	12,591 $2.35 Million
Q4 2020 Feb 16, 2021	SELL	$130.46 - $172.63 $2.67 Million - $3.53 Million	-20,477 Reduced 91.49%	1,904 $321,000
Q3 2020 Nov 16, 2020	BUY	$146.22 - $169.13 $2.69 Million - $3.11 Million	18,373 Added 458.41%	22,381 $3.31 Million
Q4 2019 Feb 14, 2020	SELL	$106.92 - $132.43 $621,846 - $770,212	-5,816 Reduced 59.2%	4,008 $527,000
Q3 2019 Nov 14, 2019	SELL	$106.79 - $116.16 $5.72 Million - $6.22 Million	-53,574 Reduced 84.5%	9,824 $1.1 Million
Q2 2019 Aug 14, 2019	BUY	$110.79 - $129.32 $4.1 Million - $4.79 Million	37,042 Added 140.54%	63,398 $7.02 Million
Q1 2019 May 15, 2019	BUY	$111.31 - $131.02 $2.59 Million - $3.05 Million	23,250 Added 748.55%	26,356 $3.42 Million
Q2 2018 Aug 13, 2018	BUY	$75.7 - $86.88 $235,124 - $269,849	3,106 New	3,106 $265,000

Others Institutions Holding LLY

# of Institutions

3,725

Shares Held

738M

Call Options Held

7.09M

Put Options Held

7.24M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $869B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capstone Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capstone Investment Advisors, LLC with notifications on news.

Account

Capstone Investment Advisors, LLC Eli Lilly & CO Transaction History